C4 Therapeutics Statistics
Total Valuation
CCCC has a market cap or net worth of $443.85 million. The enterprise value is $257.70 million.
| Market Cap | 443.85M |
| Enterprise Value | 257.70M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CCCC has 68.60 million shares outstanding. The number of shares has increased by 1.59% in one year.
| Shares Outstanding | 68.60M |
| Shares Change (YoY) | +1.59% |
| Shares Change (QoQ) | +4.14% |
| Owned by Insiders (%) | 11.62% |
| Owned by Institutions (%) | 76.51% |
| Float | 52.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.38 |
| Forward PS | 19.72 |
| PB Ratio | 1.80 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.29.
| Current Ratio | 6.34 |
| Quick Ratio | 6.29 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -94.57 |
Financial Efficiency
Return on equity (ROE) is -55.30% and return on invested capital (ROIC) is -43.85%.
| Return on Equity (ROE) | -55.30% |
| Return on Assets (ROA) | -35.80% |
| Return on Capital (ROIC) | -43.85% |
| Revenue Per Employee | $143,145 |
| Profits Per Employee | -$913,745 |
| Employee Count | 145 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCCC has paid $1.28 million in taxes.
| Income Tax | 1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +105.40% in the last 52 weeks. The beta is 3.19, so CCCC's price volatility has been higher than the market average.
| Beta (1Y) | 3.19 |
| 52-Week Price Change | +105.40% |
| 50-Day Moving Average | 8.52 |
| 200-Day Moving Average | 4.62 |
| Relative Strength Index (RSI) | 32.11 |
| Average Volume (30 Days) | 2,610,930 |
Short Selling Information
The latest short interest is 9.15 million, so 13.34% of the outstanding shares have been sold short.
| Short Interest | 9.15M |
| Short Previous Month | 5.29M |
| Short % of Shares Out | 13.34% |
| Short % of Float | 17.43% |
| Short Ratio (days to cover) | 3.24 |
Income Statement
In the last 12 months, CCCC had revenue of $20.76 million and -$132.49 million in losses. Loss per share was -$2.67.
| Revenue | 20.76M |
| Gross Profit | 20.76M |
| Operating Income | -139.03M |
| Pretax Income | -131.21M |
| Net Income | -132.49M |
| EBITDA | -121.80M |
| EBIT | -129.84M |
| Loss Per Share | -$2.67 |
Balance Sheet
The company has $257.12 million in cash and $70.98 million in debt, giving a net cash position of $186.15 million or $2.71 per share.
| Cash & Cash Equivalents | 257.12M |
| Total Debt | 70.98M |
| Net Cash | 186.15M |
| Net Cash Per Share | $2.71 |
| Equity / Book Value | 246.11M |
| Book Value Per Share | 3.59 |
| Working Capital | 228.42M |
Cash Flow
In the last 12 months, operating cash flow was -$106.84 million and capital expenditures -$1.71 million, giving a free cash flow of -$108.55 million.
| Operating Cash Flow | -106.84M |
| Capital Expenditures | -1.71M |
| Free Cash Flow | -108.55M |
| FCF Per Share | -$2.19 |
Margins
Gross margin is 100.00%, with operating and profit margins of -669.84% and -638.34%.
| Gross Margin | 100.00% |
| Operating Margin | -669.84% |
| Pretax Margin | -632.17% |
| Profit Margin | -638.34% |
| EBITDA Margin | -586.82% |
| EBIT Margin | -625.55% |
| FCF Margin | -522.96% |
Dividends & Yields
CCCC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.59% |
| Shareholder Yield | -1.59% |
| Earnings Yield | -29.85% |
| FCF Yield | -24.46% |
Analyst Forecast
The average price target for CCCC is $8.86, which is 36.94% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.86 |
| Price Target Difference | 36.94% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 165.38% |
| EPS Growth Forecast (5Y) | -4.45% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CCCC has an Altman Z-Score of -0.28 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.28 |
| Piotroski F-Score | 2 |